Latest Quarterly Report
Filed: 2026-04-27
Key Insights
- The filing covers Q1 2026 (ended March 31, 2026) for Alexandria Real Estate Equities, a life science REIT with significant real estate holdings across North America, indicating ongoing portfolio management and operational performance tracking.
- The document references multiple Alexandria-branded campuses and properties (Alexandria Center for Life Science in NYC, Mission Bay, Millbrae, and various San Diego/Seattle locations), demonstrating a diversified geographic and asset base focused on life science real estate.
- A subsequent event related to HH and EDC litigation was disclosed on April 10, 2026, which could represent material legal exposure that investors should monitor for potential financial impact.
- The company maintains unconsolidated real estate joint ventures and equity method investments, suggesting strategic partnerships that may provide growth opportunities but also add complexity to financial analysis.